187 related articles for article (PubMed ID: 25683870)
1. Falsified antimalarials: a minireview.
Chaccour C; Kaur H; Del Pozo JL
Expert Rev Anti Infect Ther; 2015 Apr; 13(4):505-9. PubMed ID: 25683870
[TBL] [Abstract][Full Text] [Related]
2. Relationship between treatment-seeking behaviour and artemisinin drug quality in Ghana.
Klein EY; Lewis IA; Jung C; Llinás M; Levin SA
Malar J; 2012 Apr; 11():110. PubMed ID: 22482747
[TBL] [Abstract][Full Text] [Related]
3. Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model.
Jackson KD; Higgins CR; Laing SK; Mwila C; Kobayashi T; Ippolito MM; Sylvia S; Ozawa S
BMC Public Health; 2020 Jul; 20(1):1083. PubMed ID: 32646393
[TBL] [Abstract][Full Text] [Related]
4. Poor-quality antimalarials further health inequities in Uganda.
Evans DR; Higgins CR; Laing SK; Awor P; Ozawa S
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii36-iii47. PubMed ID: 31816072
[TBL] [Abstract][Full Text] [Related]
5. Quality Testing of Artemisinin-Based Antimalarial Drugs in Myanmar.
Guo S; Kyaw MP; He L; Min M; Ning X; Zhang W; Wang B; Cui L
Am J Trop Med Hyg; 2017 Oct; 97(4):1198-1203. PubMed ID: 28820713
[TBL] [Abstract][Full Text] [Related]
6. Travel and fake artesunate: a risky business.
Chaccour CJ; Kaur H; Mabey D; Del Pozo JL
Lancet; 2012 Sep; 380(9847):1120. PubMed ID: 22998721
[No Abstract] [Full Text] [Related]
7. Antimalarial drug resistance in Africa: the calm before the storm?
Conrad MD; Rosenthal PJ
Lancet Infect Dis; 2019 Oct; 19(10):e338-e351. PubMed ID: 31375467
[TBL] [Abstract][Full Text] [Related]
8. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.
Dondorp AM; Newton PN; Mayxay M; Van Damme W; Smithuis FM; Yeung S; Petit A; Lynam AJ; Johnson A; Hien TT; McGready R; Farrar JJ; Looareesuwan S; Day NP; Green MD; White NJ
Trop Med Int Health; 2004 Dec; 9(12):1241-6. PubMed ID: 15598255
[TBL] [Abstract][Full Text] [Related]
9. Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.
Tivura M; Asante I; van Wyk A; Gyaase S; Malik N; Mahama E; Hostetler DM; Fernandez FM; Asante KP; Kaur H; Owusu-Agyei S
BMC Pharmacol Toxicol; 2016 Oct; 17(1):48. PubMed ID: 27788677
[TBL] [Abstract][Full Text] [Related]
10. Fake artesunate in southeast Asia.
Newton P; Proux S; Green M; Smithuis F; Rozendaal J; Prakongpan S; Chotivanich K; Mayxay M; Looareesuwan S; Farrar J; Nosten F; White NJ
Lancet; 2001 Jun; 357(9272):1948-50. PubMed ID: 11425421
[TBL] [Abstract][Full Text] [Related]
11. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
[TBL] [Abstract][Full Text] [Related]
12. Global scenario of counterfeit antimalarials: A potential threat.
Arora T; Sharma S
J Vector Borne Dis; 2019; 56(4):288-294. PubMed ID: 33269727
[TBL] [Abstract][Full Text] [Related]
13. Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study.
Ozawa S; Evans DR; Higgins CR; Laing SK; Awor P
Malar J; 2019 Jan; 18(1):5. PubMed ID: 30626380
[TBL] [Abstract][Full Text] [Related]
14. Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
Newton PN; Green MD; Mildenhall DC; Plançon A; Nettey H; Nyadong L; Hostetler DM; Swamidoss I; Harris GA; Powell K; Timmermans AE; Amin AA; Opuni SK; Barbereau S; Faurant C; Soong RC; Faure K; Thevanayagam J; Fernandes P; Kaur H; Angus B; Stepniewska K; Guerin PJ; Fernández FM
Malar J; 2011 Dec; 10():352. PubMed ID: 22152094
[TBL] [Abstract][Full Text] [Related]
15. Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria.
Kaur H; Allan EL; Mamadu I; Hall Z; Ibe O; El Sherbiny M; van Wyk A; Yeung S; Swamidoss I; Green MD; Dwivedi P; Culzoni MJ; Clarke S; Schellenberg D; Fernández FM; Onwujekwe O
PLoS One; 2015; 10(5):e0125577. PubMed ID: 26018221
[TBL] [Abstract][Full Text] [Related]
16. For severe malaria, artesunate is the answer.
Shanks GD
Lancet; 2010 Nov; 376(9753):1621-2. PubMed ID: 21062665
[No Abstract] [Full Text] [Related]
17. Counterfeit and substandard malaria drugs in Africa.
Brower V
Lancet Infect Dis; 2017 Oct; 17(10):1026-1027. PubMed ID: 28948928
[No Abstract] [Full Text] [Related]
18. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
19. Modeling the Economic Impact of Substandard and Falsified Antimalarials in the Democratic Republic of the Congo.
Ozawa S; Haynie DG; Bessias S; Laing SK; Ngamasana EL; Yemeke TT; Evans DR
Am J Trop Med Hyg; 2019 May; 100(5):1149-1157. PubMed ID: 30675851
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
Osorio L; Gonzalez I; Olliaro P; Taylor WR
Malar J; 2007 Feb; 6():25. PubMed ID: 17328806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
